Microbial antigens mediate HLA-B27 diseases via TLRs.
HLA-B27 positive individuals are predisposed to reactive arthritis developing 1-3 weeks after urogenital and gastrointestinal infections. Also ankylosing spondylitis (AS) associates strongly to HLA-B27, but no specific infection, Klebsiella pneumoniae excluded, has been linked to it. Before the discovery of its HLA-B27 association there were many reports suggesting a link between chronic prostatitis in men or pelvic inflammatory disease in women and AS. They have since been forgotten although HLA-B27 did not help to understand, why this disease has an axial and ascending nature. It is proposed that the urogenital organs form a source of damage (or danger)-associated molecular patterns (DAMPs), either exogenous pathogen-associated molecular patterns (PAMPs) from microbes or endogenous alarmins, such as uric acid, released from necrotic cells or urate deposits. DAMPs are slowly seeded from low-down upwards via the pelvic and spinal lymphatic pathways. They reach Toll-like receptors (TLRs) in their target mesenchymal stem cells, which are stimulated to ectopic enchondral bone formation leading to syndesmophytes and bamboo spine. At the same time inflammatory cytokines induce secondary osteoporosis of the spine. This new paradigm places microbes, HLA-B27 and TLRs in the pathogenic centre stage, but without pinpointing any (one) specific pathogen; instead, shared microbial patterns are indicated.
Pöllänen
Raimo
R
Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.
Sillat
Tarvo
T
Pajarinen
Jukka
J
Levón
Jaakko
J
Kaivosoja
Emilia
E
Konttinen
Yrjö T
YT
D000942:Antigens, Bacterial / Q000276:immunology* / Q000378:metabolism; D016918:Arthritis, Reactive / Q000235:genetics / Q000276:immunology / Q000378:metabolism / Q000382:microbiology; D001419:Bacteria / Q000276:immunology; D002908:Chronic Disease; D005260:Female; D015796:HLA-B27 Antigen / Q000235:genetics / Q000276:immunology*; D006801:Humans; D008297:Male; D059630:Mesenchymal Stem Cells / Q000276:immunology / Q000378:metabolism / Q000382:microbiology; D010006:Osteoblasts / Q000276:immunology / Q000378:metabolism / Q000382:microbiology; D010010:Osteoclasts / Q000276:immunology / Q000378:metabolism / Q000382:microbiology; D010012:Osteogenesis / Q000502:physiology; D000292:Pelvic Inflammatory Disease / Q000235:genetics / Q000276:immunology / Q000378:metabolism / Q000382:microbiology; D011472:Prostatitis / Q000235:genetics / Q000276:immunology / Q000378:metabolism / Q000382:microbiology; D013167:Spondylitis, Ankylosing / Q000235:genetics / Q000276:immunology* / Q000378:metabolism / Q000382:microbiology; D051193:Toll-Like Receptors / Q000276:immunology* / Q000378:metabolism
D000942:Antigens, Bacterial; D015796:HLA-B27 Antigen; D051193:Toll-Like Receptors